Glioma stem cells (GSCs) contribute to tumor recurrence and drug resistance. This study characterizes the tumorigenesis of CD133+ cells and their sensitivity to pharmacological inhibition. | Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells